Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes

Biochemical Journal

Volumn 457, Issue 3, 2014, Pages 451-461

  Stathopoulou, Konstantina ^a,b   Cuello, Friederike ^a,b   Candasamy, Alexandra J ^a   Kemp, Elizabeth M ^a   Ehler, Elisabeth ^a   Haworth, Robert S ^a   Avkiran, Metin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cardiac myocyte; Four and a half LIM (FHL); Histone deacetylase; Neurohormonal stimulation; Protein kinase; Signal transduction

Indexed keywords

ENDOTHELIN 1; FOUR AND A HALF LIM DOMAIN PROTEIN 1; FOUR AND A HALF LIM DOMAIN PROTEIN 2; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE 5; HYBRID PROTEIN; LIM PROTEIN; MYOCYTE ENHANCER FACTOR 2; PHENYLEPHRINE; POLYCYSTIN 1; PROTEIN KINASE D; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; HEART MUSCLE CELL; HETEROLOGOUS EXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; ENDOTHELIN-1; ENZYME ACTIVATION; HEART VENTRICLES; HISTONE DEACETYLASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LIM DOMAIN PROTEINS; LIM-HOMEODOMAIN PROTEINS; MEF2 TRANSCRIPTION FACTORS; MICE; MUSCLE PROTEINS; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS;

EID: 84892148008     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131026     Document Type: Article

References (50)

1. Avkiran, M., Rowland, A. J., Cuello, F. and Haworth, R. S. (2008) Protein kinase D in the cardiovascular system: emerging roles in health and disease. Circ. Res. 102, 157-163
2. Steinberg, S. F. (2012) Regulation of protein kinase D1 activity. Mol. Pharmacol. 81, 284-291
3. Haworth, R. S., Goss, M. W., Rozengurt, E. and Avkiran, M. (2000) Expression and activity of protein kinase D/protein kinase C μ in myocardium: evidence for α1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell. Cardiol. 32, 1013-1023
4. Bossuyt, J., Chang, C. W., Helmstadter, K., Kunkel, M. T., Newton, A. C., Campbell, K. S., Martin, J. L., Bossuyt, S., Robia, S. L. and Bers, D. M. (2011) Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin. J. Biol. Chem. 286, 33390-33400
5. Iwata, M., Maturana, A., Hoshijima, M., Tatematsu, K., Okajima, T., Vandenheede, J. R., Van Lint, J., Tanizawa, K. and Kuroda, S. (2005) PKC-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Biochem. Biophys. Res. Commun. 327, 1105-1113
6. Fu, Y. and Rubin, C. S. (2011) Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology. EMBO Rep. 12, 785-796
7. Haworth, R. S., Cuello, F., Herron, T. J., Franzen, G., Kentish, J. C., Gautel, M. and Avkiran, M. (2004) Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 95, 1091-1099
8. Cuello, F., Bardswell, S. C., Haworth, R. S., Yin, X., Lutz, S., Wieland, T., Mayr, M., Kentish, J. C. and Avkiran, M. (2007) Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ. Res. 100, 864-873
9. Bardswell, S. C., Cuello, F., Rowland, A. J., Sadayappan, S., Robbins, J., Gautel, M., Walker, J. W., Kentish, J. C. and Avkiran, M. (2010) Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J. Biol. Chem. 285, 5674-5682
10. Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N. and McKinsey, T. A. (2004) Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 24, 8374-8385
11. Harrison, B. C., Roberts, C. R., Hood, D. B., Sweeney, M., Gould, J. M., Bush, E. W. and McKinsey, T. A. (2004) The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol. Cell. Biol. 24, 10636-10649
12. McKinsey, T. A., Zhang, C. L. and Olson, E. N. (2000) Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. U.S.A. 97, 14400-14405
13. McKinsey, T. A., Zhang, C. L., Lu, J. and Olson, E. N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111
14. Lu, J., McKinsey, T. A., Nicol, R. L. and Olson, E. N. (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 97, 4070-4075
15. Fielitz, J., Kim, M. S., Shelton, J. M., Qi, X., Hill, J. A., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2008) Requirement of protein kinase D1 for pathological cardiac remodeling. Proc. Natl. Acad. Sci. U.S.A. 105, 3059-3063
16. Harrison, B. C., Kim, M. S., van Rooij, E., Plato, C. F., Papst, P. J., Vega, R. B., McAnally, J. A., Richardson, J. A., Bassel-Duby, R., Olson, E. N. and McKinsey, T. A. (2006) Regulation of cardiac stress signaling by protein kinase D1. Mol. Cell. Biol. 26, 3875-3888
17. Bossuyt, J., Helmstadter, K., Wu, X., Clements-Jewery, H., Haworth, R. S., Avkiran, M., Martin, J. L., Pogwizd, S. M. and Bers, D. M. (2008) Ca2+ /calmodulin-dependent protein kinase IIδ and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ. Res. 102, 695-702
18. Fimia, G. M., De Cesare, D. and Sassone-Corsi, P. (2000) A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol. Cell. Biol. 20, 8613-8622
19. Lange, S., Auerbach, D., McLoughlin, P., Perriard, E., Schafer, B. W., Perriard, J. C. and Ehler, E. (2002) Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 115, 4925-4936
20. Haworth, R. S., Stathopoulou, K., Candasamy, A. J. and Avkiran, M. (2012) Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms. Circ. Res. 110, 1585-1595
21. Haworth, R. S., Roberts, N. A., Cuello, F. and Avkiran, M. (2007) Regulation of protein kinase D activity in adult myocardium: novel counter-regulatory roles for protein kinase Cδ and protein kinase A. J. Mol. Cell. Cardiol. 43, 686-695
22. Hinson, J. S., Medlin, M. D., Taylor, J. M. and Mack, C. P. (2008) Regulation of myocardin factor protein stability by the LIM-only protein FHL2. Am. J. Physiol. Heart Circ. Physiol. 295, H1067-H1075
23. Monovich, L., Vega, R. B., Meredith, E., Miranda, K., Rao, C., Capparelli, M., Lemon, D. D., Phan, D., Koch, K. A., Chapo, J. A. et al. (2010) A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase. FEBS Lett. 584, 631-637
24. Johannessen, M., Moller, S., Hansen, T., Moens, U. and Van Ghelue, M. (2006) The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 63, 268-284
25. Shathasivam, T., Kislinger, T. and Gramolini, A. O. (2010) Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. J. Cell. Mol. Med. 14, 2702-2720
26. Morlon, A. and Sassone-Corsi, P. (2003) The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc. Natl. Acad. Sci. U.S.A. 100, 3977-3982
27. Hubbi, M. E., Gilkes, D. M., Baek, J. H. and Semenza, G. L. (2012) Four-and-a-half LIM domain proteins inhibit transactivation by hypoxia-inducible factor 1. J. Biol. Chem. 287, 6139-6149
28. Samson, T., Smyth, N., Janetzky, S., Wendler, O., Muller, J. M., Schule, R., von der Mark, H., von der Mark, K. and Wixler, V. (2004) The LIM-only proteins FHL2 and FHL3 interact with α- and β-subunits of the muscle α7β1 integrin receptor. J. Biol. Chem. 279, 28641-28652
29. McGrath, M. J., Mitchell, C. A., Coghill, I. D., Robinson, P. A. and Brown, S. (2003) Skeletal muscle LIM protein 1 (SLIM1/FHL1) induces α5β1-integrin-dependent myocyte elongation. Am. J. Physiol. Cell Physiol. 285, C1513-C1526
30. Witt, C. C., Witt, S. H., Lerche, S., Labeit, D., Back, W. and Labeit, S. (2008) Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J. 27, 350-360
31. Purcell, N. H., Darwis, D., Bueno, O. F., Muller, J. M., Schule, R. and Molkentin, J. D. (2004) Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell. Biol. 24, 1081-1095
32. Sheikh, F., Raskin, A., Chu, P. H., Lange, S., Domenighetti, A. A., Zheng, M., Liang, X., Zhang, T., Yajima, T., Gu, Y. et al. (2008) An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Invest. 118, 3870-3880
33. Kong, Y., Shelton, J. M., Rothermel, B., Li, X., Richardson, J. A., Bassel-Duby, R. and Williams, R. S. (2001) Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to β-adrenergic stimulation. Circulation 103, 2731-2738
34. Chu, P. H., Bardwell, W. M., Gu, Y., Ross, Jr, J. and Chen, J. (2000) FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell. Biol. 20, 7460-7462
35. Hojayev, B., Rothermel, B. A., Gillette, T. G. and Hill, J. A. (2012) FHL2 binds calcineurin and represses pathological cardiac growth. Mol. Cell. Biol. 32, 4025-4034
36. Bovill, E., Westaby, S., Crisp, A., Jacobs, S. and Shaw, T. (2009) Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J. Thorac. Cardiovasc. Surg. 137, 853-861
37. Backs, J., Song, K., Bezprozvannaya, S., Chang, S. and Olson, E. N. (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864
38. Backs, J., Backs, T., Neef, S., Kreusser, M. M., Lehmann, L. H., Patrick, D. M., Grueter, C. E., Qi, X., Richardson, J. A., Hill, J. A. et al. (2009) The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. U.S.A. 106, 2342-2347
39. Martini, J. S., Raake, P., Vinge, L. E., DeGeorge, Jr, B. R., Chuprun, J. K., Harris, D. M., Gao, E., Eckhart, A. D., Pitcher, J. A. and Koch, W. J. (2008) Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U.S.A. 105, 12457-12462
40. Ago, T., Liu, T., Zhai, P., Chen, W., Li, H., Molkentin, J. D., Vatner, S. F. and Sadoshima, J. (2008) A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978-993
41. Zhao, M., New, L., Kravchenko, V. V., Kato, Y., Gram, H., di Padova, F., Olson, E. N., Ulevitch, R. J. and Han, J. (1999) Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19, 21-30
42. Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J. and Lee, J. D. (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054-7066
43. Kimura, T. E., Jin, J., Zi, M., Prehar, S., Liu, W., Oceandy, D., Abe, J., Neyses, L., Weston, A. H., Cartwright, E. J. and Wang, X. (2010) Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ. Res. 106, 961-970
44. Wei, J. Q., Shehadeh, L. A., Mitrani, J. M., Pessanha, M., Slepak, T. I., Webster, K. A. and Bishopric, N. H. (2008) Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934-946
45. Meredith, E. L., Beattie, K., Burgis, R., Capparelli, M., Chapo, J., Dipietro, L., Gamber, G., Enyedy, I., Hood, D. B., Hosagrahara, V. et al. (2010) Identification of potent and selective amidobipyridyl inhibitors of protein kinase D. J. Med. Chem. 53, 5422-5438
46. Aita, Y., Kurebayashi, N., Hirose, S. and Maturana, A. D. (2011) Protein kinase D regulates the human cardiac L-type voltage-gated calcium channel through serine 1884. FEBS Lett. 585, 3903-3906
47. Xiang, S. Y., Vanhoutte, D., Del Re, D. P., Purcell, N. H., Ling, H., Banerjee, I., Bossuyt, J., Lang, R. A., Zheng, Y., Matkovich, S. J. et al. (2011) RhoA protects the mouse heart against ischemia/reperfusion injury. J. Clin. Invest. 121, 3269-3276
48. Steinbusch, L. K., Dirkx, E., Hoebers, N. T., Roelants, V., Foretz, M., Viollet, B., Diamant, M., van Eys, G., Ouwens, D. M., Bertrand, L. et al. (2013) Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes. J. Mol. Cell. Cardiol. 55, 165-173
49. Edmondson, R. D., Vondriska, T. M., Biederman, K. J., Zhang, J., Jones, R. C., Zheng, Y., Allen, D. L., Xiu, J. X., Cardwell, E. M., Pisano, M. R. and Ping, P. (2002) Protein kinase C signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol. Cell. Proteomics 1, 421-433
50. Maeno-Hikichi, Y., Chang, S., Matsumura, K., Lai, M., Lin, H., Nakagawa, N., Kuroda, S. and Zhang, J. F. (2003) A PKC-ENH-channel complex specifically modulates N-type Ca2+ channels. Nat. Neurosci. 6, 468-475